LAV, Boyu & HongShan Re-up in Gene Therapy Play
09 Aug 2024
US$ 19.00
Lilly Asia Ventures, Boyu Capital, Zoo Capital, HongShan and New Alliance Capital have made a follow-on investment ......
Related Publications
Subscribers’ Weekly...
Listen to Australia/New Zealand Divestments (Subscribers' Weekly 13 Sep 2024)...
Connect With Us
We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.
Rest assured that your email address will not be shared, as we hate spams as much as you do.